Paid Clinical Trials in Stanford, CA

As of August 2026, 429 paid clinical trials are recruiting in Stanford, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 12, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

332 clinical trials

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for Metastatic Head and Neck Squamous Cell Carcinoma

Sites in Stanford, San Francisco +48 more locations

Sponsor: Bicara Therapeutics

Sex: All·Age: 18+

Code: NCT06788990·Phase 2, Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

for Lupus Erythematosus, Systemic

Sites in Stanford, San Francisco +11 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 70

Code: NCT06897930·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth

for Autism Spectrum Disorder

1 location in Stanford

Sponsor: Stanford University

Sex: All·Age: 4 - 17·Accepts healthy volunteers

Code: NCT06362733·Recruiting·Listed Apr 2024

Apply to this trial

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for Acute Coronary Syndrome

Sites in Stanford, San Francisco +146 more locations

Sponsor: DalCor Pharmaceuticals

Sex: All·Age: 45+

Code: NCT05918861·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for Delayed Graft Function

Sites in Stanford, San Francisco +28 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06830798·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

Product Surveillance Registry

for Cardiac Rhythm Disorders

Sites in Stanford, Redwood City +127 more locations

Sponsor: Medtronic

Sex: All·Age: All ages

Code: NCT01524276·Recruiting·Listed Feb 2012

Apply to this trial

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

for Neoplasms

Sites in Stanford +14 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06551142·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

for Arrhythmia

Sites in Stanford, Salinas +83 more locations

Sponsor: Medtronic

Sex: All·Age: All ages

Code: NCT00271180·Recruiting·Listed Dec 2005

Apply to this trial

A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors

for HER-2 Positive Advanced Solid Tumors

Sites in Stanford +2 more locations

Sponsor: D3 Bio (Wuxi) Co., Ltd

Sex: All·Age: 18+

Code: NCT05957536·Phase 1·Recruiting·Listed Jul 2023

Apply to this trial